title: New Treatments for Type 2 Diabetes Mellitus and Cardiovascular Disease. The Revolution Has Begun.
authors.affiliation: Grupo de Investigación en Diabetes y Metabolismo y CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Investigación Hospital Vall d'Hebron (VHIR), Barcelona, Spain. Electronic address: rafael.simo@vhir.org.
authors.forename: Rafael
authors.initials: R
authors.lastname: Simó
authors.affiliation: Grupo de Investigación en Diabetes y Metabolismo y CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Investigación Hospital Vall d'Hebron (VHIR), Barcelona, Spain.
authors.forename: Cristina
authors.initials: C
authors.lastname: Hernández
mesh_terms: D000218:Adamantane / Q000031:analogs & derivatives / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology; D004151:Dipeptides / Q000627:therapeutic use; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use; D005960:Glucosides / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000069450:Liraglutide / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D012306:Risk; D000068900:Sitagliptin Phosphate / Q000627:therapeutic use; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D000097789:Glucagon-Like Peptide-1 Receptor Agonists; D000067758:Glucagon-Like Peptide-2 Receptor
chemical_list: D000218:Adamantane; D001559:Benzhydryl Compounds; D004151:Dipeptides; D054873:Dipeptidyl-Peptidase IV Inhibitors; D005960:Glucosides; D007004:Hypoglycemic Agents; D000069450:Liraglutide; D010455:Peptides; D010880:Piperidines; D000068900:Sitagliptin Phosphate; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D014498:Uracil; D000097789:Glucagon-Like Peptide-1 Receptor Agonists; C479460:lixisenatide; D000067758:Glucagon-Like Peptide-2 Receptor; C502994:saxagliptin; C570240:empagliflozin; C520853:alogliptin